17-(3,4-Dimethoxyphenethyl)-3-methoxymorphinan

Suppliers

Names

[ CAS No. ]:
63690-30-2

[ Name ]:
17-(3,4-Dimethoxyphenethyl)-3-methoxymorphinan

[Synonym ]:
(-)-17-(3,4-Dimethoxyphenethyl)-3-methoxymorphinan
Morphinan,17-(3,4-dimethoxyphenethyl)-3-methoxy-,(-)

Chemical & Physical Properties

[ Density]:
1.16g/cm3

[ Boiling Point ]:
552ºC at 760 mmHg

[ Molecular Formula ]:
C27H35NO3

[ Molecular Weight ]:
421.57200

[ Flash Point ]:
149.8ºC

[ Exact Mass ]:
421.26200

[ PSA ]:
30.93000

[ LogP ]:
4.95140

[ Index of Refraction ]:
1.599

Toxicological Information

CHEMICAL IDENTIFICATION

RTECS NUMBER :
QC7695000
CHEMICAL NAME :
Morphinan, 17-(3,4-dimethoxyphenethyl)-3-methoxy-, (-)-
CAS REGISTRY NUMBER :
63690-30-2
BEILSTEIN REFERENCE NO. :
0057617
LAST UPDATED :
199712
DATA ITEMS CITED :
2
MOLECULAR FORMULA :
C27-H35-N-O3
MOLECULAR WEIGHT :
421.63
WISWESSER LINE NOTATION :
T6 G666/FQ 2AF Q FX ONT&TTJ IO1 O2R CO1 DO1

HEALTH HAZARD DATA

ACUTE TOXICITY DATA

TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Subcutaneous
SPECIES OBSERVED :
Rodent - mouse
DOSE/DURATION :
600 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
31ZPAG "Synthetic Analgesics," Oxford, Pergamon Press, 1966 Volume(issue)/page/year: 2,87,1966
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Intravenous
SPECIES OBSERVED :
Rodent - mouse
DOSE/DURATION :
26 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
31ZPAG "Synthetic Analgesics," Oxford, Pergamon Press, 1966 Volume(issue)/page/year: 2,87,1966

Synthetic Route


Related Compounds

  • 2-(3,4-dimethoxyphenethyl)-3-hydroxyisoindolin-1-one
  • N-(3,4-dimethoxyphenethyl)-3,4-methylenedioxybenzamide
  • N-(3,4-dimethoxyphenethyl)-3,4-dimethoxycyclobutene-1-carboxamide
  • N-(3,4-dimethoxyphenethyl)-3,5-dinitrobenzamide
  • 4-(3,4-Dimethoxyphenethyl)-3,4,5,6-tetrahydro-2,6-methano-2H-1,4-benzoxazocine
  • 1-(3,4-dimethoxyphenethyl)-3-ethyl-5-(phenylsulfinyl)piperidine-2,6-dione
  • 4-((Cyclohexylamino)methyl)benzoic acid hydrochloride
  • 1-(3-Bromopropyl)-2-ethyl-5-iodobenzene
  • Urea, Na(2)-(4-butylphenyl)-N-(2-hydroxyethyl)-N-2-propen-1-yl-
  • 1-[(2,4-Dichlorophenyl)methyl]-N-(1,1-dimethylethyl)-2-methyl-1H-indole-3-methanamine
  • 2-Methoxy-6-(pyrazol-1-yl)-benzonitrile
  • 2-(Aminomethyl)-5-cyano-6-(difluoromethyl)-3-(trifluoromethyl)pyridine
  • 1H-3-Benzazepin-7-ol, 8-chloro-2,3,4,5-tetrahydro-5-(3-iodophenyl)-3-methyl-, (S)-
  • (4-Methyl-tetrahydro-furan-2-yl)-methanol
  • N-(1-cyanocyclopentyl)-2-[4-(4-fluorobenzenesulfonyl)-1,4-diazepan-1-yl]acetamide
  • 4,5,6,7-Tetrahydrobenzo[d]isoxazole-3-carbaldehyde